Page last updated: 2024-08-25

rosiglitazone and Compensatory Hyperinsulinemia

rosiglitazone has been researched along with Compensatory Hyperinsulinemia in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	24 (75.00)	29.6817
2010's	8 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choe, C; Ciaraldi, TP; Farr, O; Henry, RR; Hwang, WM; Kang, MC; Kim, SS; Kim, YB; Lim, DM; Mantzoros, C; Park, KS; Seo, JA	1
Anthony, J; Bhumra, SK; Deka, N; Kelkar, A; Marita, AR; Mutt, S; Mutt, SJ; Ranjith, V; Sharma, S; Sivaramakrishnan, H; Wilankar, C	1
Chen, HS; Juan, CC; Lin, HD; Wu, TE	1
Andres, J; Biedasek, K; Bobbert, T; Clemenz, M; Kintscher, U; Mai, K; Meinus, S; Möhlig, M; Pfeiffer, AF; Reinecke, F; Sabath, M; Spranger, J; Spuler, S; Weicht, J; Weickert, MO	1
Liou, SS; Liu, IM; Tzeng, TF	1
Denner, L; Dineley, KT; Rodriguez-Rivera, J	1
Meng, Q; Qian, T; Yang, Z; Zhou, L	1
Benthem, L; Boersma, G; Scheurink, AJ; Steimer, TJ; van Dijk, G	1
Feng, Y; Ruan, KF; Wang, LY; Wang, S; Wang, Y; Xu, DS	1
Jyothi Kumari, P; Lakshmi, BS; Sangeetha, KN; Shilpa, K	1
Banday, AA; Hussain, T; Lokhandwala, MF; Umrani, DN	1
Cleasby, ME; Livingstone, DE; Nyirenda, MJ; Seckl, JR; Walker, BR	1
Ehrenborg, E; Eriksson, P; Fisher, RM; Hamsten, A; Kannisto, K; Korsheninnikova, E; Silveira, A; Sutinen, J; Yki-Järvinen, H	1
Gavish, D; Gavish, E; Leibovitz, E; Leibovitz, Z; Matas, D; Matas, Z; Shargorodsky, M; Wainstein, G; Wainstein, J; Zimlichman, R	1
Barringhaus, KG; Chen, M; Czarnik, AC; Hesselbacher, S; Ley, K; Nadler, J; Phillips, JW; Sanders, JM; Sarembock, IJ; Yang, Z	1
Fischer, S; Fuecker, K; Gross, P; Hanefeld, M; Passauer, J; Pistrosch, F	1
Agrawal, A; Bennett, SM; Elasha, H; Heise, M; Jones, NP; Walker, M; Wilding, JP	1
Grinspoon, S; Hadigan, C; Havers, F; Sax, PE; Thomas, A; Yawetz, S	1
Fischer, S; Gross, P; Herbrig, K; Oelschlaegel, U; Passauer, J; Pistrosch, F; Richter, S	1
Bauer, TA; Regensteiner, JG; Reusch, JE	1
Németh, J; Pankucsi, C; Peitl, B; Szilvássy, Z	1
Alston-Smith, BL; Basar, MT; Fielding, RA; Grinspoon, S; Koletar, SL; Mulligan, K; Parker, RA; Schouten, JT; Wininger, DA; Yang, Y	1
Kesäniemi, YA; Kunnari, A; Majuri, A; Morin-Papunen, L; Rautio, K; Ruokonen, A; Santaniemi, M; Tapanainen, JS; Ukkola, O; Vartiainen, J	1
Brunani, A; Castagna, G; Caumo, A; Graci, S; Liuzzi, A; Viberti, G	1
Boaz, M; Gavish, D; Michaelova, K; Shargorodsky, M; Zimlichman, R	1
Ecelbarger, CA; Halagappa, VK; Hu, X; Riazi, S; Tiwari, S	1
Benavides, S; Romo, A	1
Daubresse, JC	1
Boehm, M; Crombie, DL; Davies, PJ; Depre, C; Heyman, RA; Leibowitz, MD; Liu, S; Nagy, L; Singh Ahuja, H; Tontonoz, P	1
Jacinto, SM; Ljung, B; Oakes, ND; Thalén, PG	1
Befroy, D; Cline, GW; Dufour, S; Enocksson, S; Hundal, RS; Inzucchi, SE; Lebon, V; Mayerson, AB; Petersen, KF; Shulman, GI	1

Reviews

1 review(s) available for rosiglitazone and Compensatory Hyperinsulinemia

Article	Year
[The importance of syndrome X in daily practice]. Revue medicale de Bruxelles, 2000, Volume: 21, Issue:6 Topics: Anthropometry; Cardiovascular Diseases; Diet, Reducing; Exercise; Humans; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Lipoproteins, HDL; Lipoproteins, LDL; Obesity; Rosiglitazone; Thiazoles; Thiazolidinediones	2000

Trials

9 trial(s) available for rosiglitazone and Compensatory Hyperinsulinemia

Article	Year
Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. Arteriosclerosis, thrombosis, and vascular biology, 2003, Apr-01, Volume: 23, Issue:4 Topics: Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Female; HIV Infections; Humans; Hyperinsulinism; Hypertriglyceridemia; Interleukin-6; Leptin; Lipodystrophy; Liver; Male; Middle Aged; Organ Specificity; Plasminogen Activator Inhibitor 1; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Subcutaneous Tissue; Thiazolidinediones; Transcription Factors	2003
Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus. American journal of hypertension, 2003, Volume: 16, Issue:8 Topics: Adult; Aged; Arteries; Blood Glucose; Blood Pressure; Compliance; Diabetes Mellitus, Type 2; Elasticity; Female; Heart Rate; Humans; Hyperinsulinism; Hypoglycemic Agents; Male; Middle Aged; Risk Factors; Rosiglitazone; Thiazolidinediones; Vascular Resistance; Weight Gain	2003
In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Diabetes care, 2004, Volume: 27, Issue:2 Topics: Acetylcholine; Adult; Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Fasting; Female; Glucose Clamp Technique; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Reference Values; Rosiglitazone; Thiazolidinediones	2004
Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance. Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:5 Topics: Adult; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Postprandial Period; Rosiglitazone; Thiazolidinediones	2004
Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial. Annals of internal medicine, 2004, May-18, Volume: 140, Issue:10 Topics: Adiponectin; Adult; Double-Blind Method; Fatty Acids, Nonesterified; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Lipids; Male; Middle Aged; Proteins; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors	2004
Rosiglitazone improves exercise capacity in individuals with type 2 diabetes. Diabetes care, 2005, Volume: 28, Issue:12 Topics: Adipose Tissue; Adult; Blood Glucose; Body Mass Index; Brachial Artery; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise; Fasting; Glucose Clamp Technique; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Middle Aged; Oxygen Consumption; Physical Fitness; Rosiglitazone; Thiazolidinediones	2005
Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio. AIDS (London, England), 2007, Jan-02, Volume: 21, Issue:1 Topics: Adult; Body Composition; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Hyperinsulinism; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Rosiglitazone; Statistics, Nonparametric; Thiazolidinediones; Treatment Outcome; Waist-Hip Ratio	2007
Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study. European journal of endocrinology, 2007, Volume: 156, Issue:2 Topics: Adiponectin; Adult; Female; Ghrelin; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Peptide Hormones; Placebos; Polycystic Ovary Syndrome; Resistin; Rosiglitazone; Thiazolidinediones	2007
Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients. Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:6 Topics: Adipose Tissue; Adolescent; Adult; Aged; B-Lymphocytes; Blood Glucose; Body Composition; Female; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Male; Metformin; Middle Aged; Obesity; Obesity, Morbid; Rosiglitazone; Thiazolidinediones; Weight Loss	2008

Other Studies

22 other study(ies) available for rosiglitazone and Compensatory Hyperinsulinemia

Article	Year
Circulating ApoJ is closely associated with insulin resistance in human subjects. Metabolism: clinical and experimental, 2018, Volume: 78 Topics: Blood Glucose; Clusterin; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Clamp Technique; Homeostasis; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Risk Factors; Rosiglitazone; Thiazolidinediones	2018
Discovery of p1736, a novel antidiabetic compound that improves peripheral insulin sensitivity in mice models. PloS one, 2013, Volume: 8, Issue:10 Topics: Adipocytes; Aminopyridines; Animals; Diabetes Mellitus, Type 2; Drug Discovery; Glucose; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metformin; Mice; Mice, Mutant Strains; Rosiglitazone; Sulfonamides; Thiazolidinediones	2013
Myocardial heat shock protein 60 expression in insulin-resistant and diabetic rats. The Journal of endocrinology, 2009, Volume: 200, Issue:2 Topics: Amlodipine; Animals; Antihypertensive Agents; Chaperonin 60; Diabetes Mellitus, Experimental; Disease Models, Animal; Fructose; Gene Expression; Hyperinsulinism; Hypertension; Hypoglycemic Agents; Insulin Resistance; Male; Myocardium; Rats; Rats, Sprague-Dawley; Rosiglitazone; Streptozocin; Thiazolidinediones	2009
Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21. Diabetes, 2009, Volume: 58, Issue:7 Topics: Cell Line; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Female; Fibroblast Growth Factors; Gene Expression Regulation; Glucose Clamp Technique; Glycerol; Homeostasis; Humans; Hyperinsulinism; Hypoglycemic Agents; Lecithins; Male; Obesity; PPAR alpha; PPAR gamma; Reference Values; RNA, Messenger; Rosiglitazone; Thiazolidinediones	2009
Abelmoschus moschatus (Malvaceae), an aromatic plant, suitable for medical or food uses to improve insulin sensitivity. Phytotherapy research : PTR, 2010, Volume: 24, Issue:2 Topics: Abelmoschus; Animals; Flavonoids; Fructose; Glucose Tolerance Test; Glucose Transporter Type 4; Hyperinsulinism; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Phenols; Phosphatidylinositol 3-Kinases; Phosphorylation; Plant Extracts; Rats; Rats, Wistar; Receptor, Insulin; Rosiglitazone; Thiazolidinediones	2010
Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status. Behavioural brain research, 2011, Jan-01, Volume: 216, Issue:1 Topics: Alzheimer Disease; Analysis of Variance; Animals; Area Under Curve; Association Learning; Blood Glucose; Cognition; Disease Models, Animal; Hyperinsulinism; Hypoglycemic Agents; Insulin; Memory; Mice; Mice, Transgenic; Rosiglitazone; Thiazolidinediones	2011
Ginkgo biloba extract enhances glucose tolerance in hyperinsulinism-induced hepatic cells. Journal of natural medicines, 2011, Volume: 65, Issue:1 Topics: Cell Line; Ginkgo biloba; Glucokinase; Glucose; Glucose-6-Phosphatase; Hepatocytes; Humans; Hyperinsulinism; Insulin; Insulin Receptor Substrate Proteins; Plant Extracts; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones	2011
Pharmacological treatment of hyperinsulineamia in rats depends on coping style. European journal of pharmacology, 2011, Mar-01, Volume: 654, Issue:1 Topics: Adaptation, Psychological; Animals; Blood Glucose; Disease Susceptibility; Glucose Tolerance Test; Hyperinsulinism; Hypoglycemic Agents; Insulin; Male; Mifepristone; Rats; Rosiglitazone; Thiazolidinediones	2011
MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model. Journal of ethnopharmacology, 2012, Aug-30, Volume: 143, Issue:1 Topics: Animals; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Experimental; Female; Glucose Tolerance Test; Glucose Transporter Type 4; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Mice; Mice, Inbred C57BL; Ophiopogon; Phosphatidylinositol 3-Kinases; Phytotherapy; Plant Extracts; Plant Roots; Polysaccharides; Proto-Oncogene Proteins c-akt; Rosiglitazone; Signal Transduction; Thiazolidinediones; Triglycerides	2012
Reversal of dexamethasone induced insulin resistance in 3T3L1 adipocytes by 3β-taraxerol of Mangifera indica. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2013, Feb-15, Volume: 20, Issue:3-4 Topics: 3T3-L1 Cells; Adipocytes; Animals; Biomarkers; Dexamethasone; Disease Models, Animal; Drug Evaluation, Preclinical; Glucose; Glucose Transporter Type 4; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Mangifera; Mice; Oleanolic Acid; Phosphatidylinositol 3-Kinases; Phytotherapy; Plant Extracts; Rosiglitazone; Thiazolidinediones	2013
Rosiglitazone treatment restores renal dopamine receptor function in obese Zucker rats. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:6 Topics: Animals; Benzazepines; Binding, Competitive; Blood Glucose; Blood Pressure; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Epithelial Cells; Glucose; Hyperinsulinism; Hypoglycemic Agents; Insulin; Kidney; Kidney Tubules, Proximal; Male; Obesity; Rats; Rats, Zucker; Receptors, Dopamine D1; Rosiglitazone; Sodium-Potassium-Exchanging ATPase; Thiazoles; Thiazolidinediones	2002
Is programming of glucocorticoid receptor expression by prenatal dexamethasone in the rat secondary to metabolic derangement in adulthood? European journal of endocrinology, 2003, Volume: 148, Issue:1 Topics: Animals; Appetite; Body Weight; Corticosterone; Dexamethasone; Female; Gene Expression; Glucocorticoids; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metformin; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Receptors, Glucocorticoid; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones	2003
Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes. Circulation, 2003, Oct-21, Volume: 108, Issue:16 Topics: Animals; Blood Glucose; Carotid Arteries; Carotid Artery Injuries; Cells, Cultured; Diabetes Mellitus, Type 2; Diet; Disease Models, Animal; Female; Homozygote; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Lipids; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Rosiglitazone; Thiazoles; Thiazolidinediones; Tunica Intima	2003
Summaries for patients. Rosiglitazone treatment for fat redistribution and metabolic abnormalities caused by anti-HIV therapy. Annals of internal medicine, 2004, May-18, Volume: 140, Issue:10 Topics: Adiponectin; Adult; Double-Blind Method; Fatty Acids, Nonesterified; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Lipids; Male; Middle Aged; Proteins; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors	2004
PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis, 2005, Volume: 183, Issue:1 Topics: AC133 Antigen; Antigens, CD; Antigens, CD34; Cell Count; Cell Division; Cell Movement; Cells, Cultured; Cholesterol; Diabetes Mellitus, Type 2; Endothelial Cells; Endothelium, Vascular; Female; Glucose Clamp Technique; Glycated Hemoglobin; Glycoproteins; Humans; Hyperinsulinism; Insulin Resistance; Lipoproteins, LDL; Male; Middle Aged; Monocytes; Peptides; PPAR gamma; Rosiglitazone; Single-Blind Method; Thiazolidinediones; Triglycerides; Vascular Endothelial Growth Factor A	2005
Insulin sensitization induced by oral cicletanine in conscious rabbits. Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 373, Issue:6 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Pressure; Blood Vessels; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Glucose Clamp Technique; Heart Rate; Hypercholesterolemia; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Myocardium; Nitric Oxide; Pyridines; Rabbits; Rosiglitazone; Thiazolidinediones	2006
Effect of long-term treatment with rosiglitazone on arterial elasticity and metabolic parameters in patients with Type 2 diabetes mellitus: a 2-year follow-up study. Diabetic medicine : a journal of the British Diabetic Association, 2007, Volume: 24, Issue:11 Topics: Arteries; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Elasticity; Female; Follow-Up Studies; Humans; Hyperinsulinism; Hypoglycemic Agents; Male; Middle Aged; Prospective Studies; Rosiglitazone; Thiazolidinediones; Time; Treatment Outcome; Vascular Resistance	2007
Reduced expression of insulin receptors in the kidneys of insulin-resistant rats. Journal of the American Society of Nephrology : JASN, 2007, Volume: 18, Issue:10 Topics: Animals; Gene Expression; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Kidney; Male; PPAR gamma; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Insulin; Rosiglitazone; Thiazolidinediones	2007
Treatment options in insulin resistance obesity-related acanthosis nigricans. The Annals of pharmacotherapy, 2008, Volume: 42, Issue:7 Topics: Acanthosis Nigricans; Adolescent; Adult; Calcitriol; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Octreotide; Retinoids; Rosiglitazone; Thiazolidinediones; Vitamin D	2008
Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Molecular pharmacology, 2001, Volume: 59, Issue:4 Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression; Glucose Tolerance Test; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Liver; Male; Muscle, Skeletal; Nicotinic Acids; Obesity; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors	2001
Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Diabetes, 2001, Volume: 50, Issue:5 Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Fasting; Fatty Acids, Nonesterified; Glucose Clamp Technique; Humans; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Kinetics; Lipid Mobilization; Lipoproteins, VLDL; Liver; Male; Metabolic Clearance Rate; Muscle, Skeletal; Obesity; Oxidation-Reduction; Polyethylene Glycols; Postprandial Period; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Triglycerides	2001
The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes, 2002, Volume: 51, Issue:3 Topics: Adipocytes; Adipose Tissue; Blood Glucose; Body Composition; Calorimetry, Indirect; Diabetes Mellitus, Type 2; Fatty Acids; Glucose Clamp Technique; Glycated Hemoglobin; Glycerol; Humans; Hyperinsulinism; Insulin; Kinetics; Lipids; Lipolysis; Liver; Magnetic Resonance Spectroscopy; Microdialysis; Middle Aged; Muscle, Skeletal; Oxidation-Reduction; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides	2002